ArticleRadiology and oncology2021

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy - single institute experience.

Martina Vrankar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.